• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why Mainz Biomed Shares Are Trading Higher By Around 16%; Here Are 20 Stocks Moving Premarket

    7/9/24 5:33:25 AM ET
    $ALBT
    $BEEM
    $GLMD
    $GNLN
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Semiconductors
    Technology
    Get the next $ALBT alert in real time by email

    Shares of Mainz Biomed N.V. (NASDAQ:MYNZ) rose sharply in today's pre-market trading after the company announced submission for the FDA Breakthrough Device Designation for its next generation CRC screening test.

    Mainz Biomed shares jumped 16% to $0.5534 in pre-market trading.

    Here are some other stocks moving in pre-market trading.

    Gainers

    • Pineapple Energy Inc. (NASDAQ:PEGY) rose 85% to $2.22 in pre-market trading. Pineapple Energy engaged Conduit Capital to provide structural internal support, staffing, and assistance with capital raising activities.
    • Zapp Electric Vehicles Group Limited (NASDAQ:ZAPP) shares rose 43.5% to $13.26 in pre-market trading after gaining 127% on Monday.
    • Trinity Place Holdings Inc. (NYSE:TPHS) shares rose 33.1% to $0.1625 in pre-market trading after gaining around 7% on Monday.
    • Nuwellis, Inc. (NASDAQ:NUWE) gained 14.3% to $4.55 in pre-market trading. Nuwellis was recently granted European patent EP3873343 for “Neonatal And Pediatric Blood Filtration System”.
    • Beam Global (NASDAQ:BEEM) shares gained 13.5% to $7.37 in pre-market trading after jumping around 18% on Monday. Beam Global recently announced a year-over-year increase in second-quarter new orders.
    • Zapata Computing Holdings Inc. (NASDAQ:ZPTA) shares climbed 13.3% to $0.6501 in pre-market trading after gaining 7% on Monday. Zapata Computing Holdings and D-Wave Quantum Inc (NYSE:QBTS), on Monday, announced a significant expansion of their joint commercial partnership.
    • Portage Biotech Inc. (NASDAQ:PRTG) gained 8.2% to $0.1601 in pre-market trading.
    • Galmed Pharmaceuticals Ltd.. (NASDAQ:GLMD) rose 7.5% to $0.33 in pre-market trading after declining 7% on Monday.
    • Nikola Corporation (NASDAQ:NKLA) shares gained 7% to $11.22 in pre-market trading after surging around 17% on Monday.

    Losers

    • Indivior PLC (NASDAQ:INDV) shares fell 43.2% to $8.71 in pre-market trading after the company lowered its fiscal 2024 guidance.
    • Shapeways Holdings, Inc. (NASDAQ:SHPW) shares fell 21.5% to $0.3821 in pre-market trading after jumping 132% on Monday.
    • Greenlane Holdings, Inc. (NASDAQ:GNLN) shares declined 18.1% to $0.2370 in pre-market trading after gaining 5% on Monday.
    • Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) fell 15.8% to $0.5998 in pre-market trading after announcing a proposed public offering.
    • Novo Integrated Sciences, Inc. (NASDAQ:NVOS) shares fell 13.8% to $0.65 in pre-market trading.
    • Hywin Holdings Ltd – ADR (NASDAQ:HYW) shares dipped 12.7% to $0.34 in pre-market trading after jumping over 25% on Monday.
    • Inuvo, Inc. (NYSE:INUV) shares fell 10.6% to $0.2342 in pre-market trading.
    • Helios Technologies, Inc. (NYSE:HLIO) shares declined 10.1% to $41.67 in pre-market trading after the company announced leadership team update. The company named Sean Bagan as Interim President and CEO.
    • Avalon GloboCare Corp. (NASDAQ:ALBT) shares fell 9.8% to $0.46 in pre-market trading after declining over 4% on Monday.
    • Qualigen Therapeutics, Inc. (NASDAQ:QLGN) fell 8.5% to $0.2562 in pre-market trading.

    Now Read This: Wall Street’s Most Accurate Analysts Say Buy These 3 Utilities Stocks Delivering High-Dividend Yields

    Get the next $ALBT alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ALBT
    $BEEM
    $GLMD
    $GNLN

    CompanyDatePrice TargetRatingAnalyst
    D-Wave Quantum Inc.
    $QBTS
    2/12/2026Buy
    TD Cowen
    Helios Technologies Inc.
    $HLIO
    1/20/2026$80.00Overweight
    Analyst
    D-Wave Quantum Inc.
    $QBTS
    12/17/2025$35.00Outperform
    Wedbush
    D-Wave Quantum Inc.
    $QBTS
    12/11/2025$46.00Outperform
    Mizuho
    D-Wave Quantum Inc.
    $QBTS
    12/3/2025$44.00Outperform
    Evercore ISI
    Indivior Pharmaceuticals Inc.
    $INDV
    8/6/2025$27.00Buy
    H.C. Wainwright
    D-Wave Quantum Inc.
    $QBTS
    8/5/2025$26.00Buy
    Stifel
    D-Wave Quantum Inc.
    $QBTS
    7/29/2025$30.00Buy
    Rosenblatt
    More analyst ratings

    $ALBT
    $BEEM
    $GLMD
    $GNLN
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Greenlane Holdings, Inc. Announces 1-for-8 Reverse Stock Split

    BOCA RATON, Fla., April 01, 2026 (GLOBE NEWSWIRE) -- Greenlane Holdings, Inc. ("Greenlane" or the "Company") (NASDAQ:GNLN), a company with a Berachain-focused Digital Asset Treasury ("DAT"), today announced that it will effect a reverse stock split of its outstanding shares of common stock at a ratio of 1-for-8, to be effective as of 12:01 a.m. Eastern Time on April 6, 2026. Greenlane's common stock will begin trading on a reverse stock split-adjusted basis at the opening of the market on April 6, 2026. Following the reverse stock split, Greenlane's common stock will continue to trade on The Nasdaq Capital Market under the symbol "GNLN" with the new CUSIP number, 395330 608. The reverse s

    4/1/26 8:00:00 AM ET
    $GNLN
    Durable Goods
    Consumer Discretionary

    Trinity Place Holdings Inc. Reports Fourth Quarter Financial Results

    Trinity Place Holdings Inc. (OTC:TPHS) (the "Company," "we," "our," or "us") today announced operating results for its fourth quarter and the year ended December 31, 2025. The Company is an intellectual property holding, investment, and commercialization company. We own and control a portfolio of intellectual property assets focused on the consumer sector, a legacy of our predecessor, Syms Corp. ("Syms"), including FilenesBasement.com, our rights to the Stanley Blacker® brand, as well as the intellectual property associated with the Running of the Brides® event and the An Educated Consumer is Our Best Customer® slogan. Our strategy today centers on monetizing these assets through brand li

    3/31/26 6:40:00 PM ET
    $TPHS
    Building operators
    Real Estate

    Greenlane Reports Fourth Quarter and Full Year 2025 Financial Results

    BOCA RATON, Fla., March 31, 2026 (GLOBE NEWSWIRE) -- Greenlane Holdings, Inc. ("Greenlane" or the "Company") (NASDAQ:GNLN), a publicly traded digital asset treasury company focused on the acquisition, management, and strategic deployment of BERA, the native token of the Berachain blockchain network, today reported its financial results for the fourth quarter and full year ended December 31, 2025. Digital Asset Treasury Strategy In October 2025, following the closing of a private placement that raised $110.7M in capital, Greenlane adopted a Treasury Policy and initiated a strategic shift toward a digital asset treasury strategy focused on BERA, the native token of the Berachain blockchain

    3/31/26 5:01:24 PM ET
    $GNLN
    Durable Goods
    Consumer Discretionary

    $ALBT
    $BEEM
    $GLMD
    $GNLN
    SEC Filings

    View All

    Inuvo Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits

    8-K - Inuvo, Inc. (0000829323) (Filer)

    4/3/26 8:58:54 AM ET
    $INUV
    Advertising
    Consumer Discretionary

    SEC Form DEF 14A filed by Nuwellis Inc.

    DEF 14A - Nuwellis, Inc. (0001506492) (Filer)

    4/2/26 5:01:21 PM ET
    $NUWE
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    SEC Form PRE 14A filed by Avalon GloboCare Corp.

    PRE 14A - Avalon GloboCare Corp. (0001630212) (Filer)

    4/2/26 4:27:05 PM ET
    $ALBT
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $ALBT
    $BEEM
    $GLMD
    $GNLN
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    TD Cowen initiated coverage on D-Wave Quantum

    TD Cowen initiated coverage of D-Wave Quantum with a rating of Buy

    2/12/26 7:24:12 AM ET
    $QBTS
    EDP Services
    Technology

    Analyst initiated coverage on Helios Technologies with a new price target

    Analyst initiated coverage of Helios Technologies with a rating of Overweight and set a new price target of $80.00

    1/20/26 8:11:19 AM ET
    $HLIO
    Metal Fabrications
    Industrials

    Wedbush initiated coverage on D-Wave Quantum with a new price target

    Wedbush initiated coverage of D-Wave Quantum with a rating of Outperform and set a new price target of $35.00

    12/17/25 9:18:48 AM ET
    $QBTS
    EDP Services
    Technology

    $ALBT
    $BEEM
    $GLMD
    $GNLN
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Ryan Barbara bought $249 worth of shares (8 units at $31.09), increasing direct ownership by 0.14% to 5,724 units (SEC Form 4)

    4 - Indivior Pharmaceuticals, Inc. (0001625297) (Issuer)

    3/13/26 4:25:33 PM ET
    $INDV
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Director Kingsley Stuart A bought $29,953 worth of shares (940 units at $31.86), increasing direct ownership by 20% to 5,582 units (SEC Form 4)

    4 - Indivior Pharmaceuticals, Inc. (0001625297) (Issuer)

    3/11/26 9:54:36 AM ET
    $INDV
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Director Ryan Barbara bought $1,009 worth of shares (31 units at $32.56), increasing direct ownership by 0.55% to 5,716 units (SEC Form 4)

    4 - Indivior Pharmaceuticals, Inc. (0001625297) (Issuer)

    3/11/26 8:12:31 AM ET
    $INDV
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ALBT
    $BEEM
    $GLMD
    $GNLN
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Ruiz Wallace D

    4 - Inuvo, Inc. (0000829323) (Issuer)

    4/3/26 10:07:57 AM ET
    $INUV
    Advertising
    Consumer Discretionary

    SEC Form 4 filed by Howe Richard K

    4 - Inuvo, Inc. (0000829323) (Issuer)

    4/3/26 10:07:56 AM ET
    $INUV
    Advertising
    Consumer Discretionary

    SEC Form 4 filed by Evans Jeremy Scott

    4 - HELIOS TECHNOLOGIES, INC. (0001024795) (Issuer)

    4/2/26 4:07:57 PM ET
    $HLIO
    Metal Fabrications
    Industrials

    $ALBT
    $BEEM
    $GLMD
    $GNLN
    Leadership Updates

    Live Leadership Updates

    View All

    Greenlane Reports Fourth Quarter and Full Year 2025 Financial Results

    BOCA RATON, Fla., March 31, 2026 (GLOBE NEWSWIRE) -- Greenlane Holdings, Inc. ("Greenlane" or the "Company") (NASDAQ:GNLN), a publicly traded digital asset treasury company focused on the acquisition, management, and strategic deployment of BERA, the native token of the Berachain blockchain network, today reported its financial results for the fourth quarter and full year ended December 31, 2025. Digital Asset Treasury Strategy In October 2025, following the closing of a private placement that raised $110.7M in capital, Greenlane adopted a Treasury Policy and initiated a strategic shift toward a digital asset treasury strategy focused on BERA, the native token of the Berachain blockchain

    3/31/26 5:01:24 PM ET
    $GNLN
    Durable Goods
    Consumer Discretionary

    Mainz Biomed Announces Appointment of Robert Liscouski as Chairman of the Board of Directors

    BERKELEY, Calif., March 11, 2026 (GLOBE NEWSWIRE) -- Mainz Biomed N.V. (NASDAQ:MYNZ), a molecular genetics diagnostic company specializing in the early detection of cancer, today announced that Robert P. Liscouski has been appointed Chairman of its Board of Directors. Further, the Company announced that it plans to change its name to Quantum Cyber and change its Nasdaq ticker symbol to QUCY, beginning on March 12, 2026. The permanent election of Mr. Liscouski and the change of Company name will become effective at the Company's extraordinary general meeting, being planned for April 2026. The Company will begin doing business as Quantum Cyber and trading under the symbol QUCY beginning on M

    3/11/26 7:30:00 AM ET
    $MYNZ
    $QUBT
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Computer Software: Prepackaged Software
    Technology

    Industry Leaders Join Zapata's Growth Advisory Board, Validating Its Hardware-Agnostic, Application-Driven Approach

    BOSTON, March 10, 2026 (GLOBE NEWSWIRE) -- Zapata Quantum (OTC:ZPTA) ("Zapata", "Zapata Quantum" or the "Company"), a pioneer in quantum computing application and algorithm development, today announced the appointment of three quantum industry and vertical market veterans to its Growth Advisory Board (GAB): Steve Suarez, Steven Lau and M. Jeff Brittain. Within the quantum space, Zapata has unique and deep customer experience developing and analyzing foundational quantum applications end-to-end from use case to execution across multiple high-value domains. These areas include chemistry, finance, supply chain and defense with leaders such as BP, BASF, DARPA, BMW, BBVA and more. "We're hono

    3/10/26 8:00:00 AM ET
    $ZPTA
    Blank Checks
    Finance

    $ALBT
    $BEEM
    $GLMD
    $GNLN
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Beam Global

    SC 13G/A - Beam Global (0001398805) (Subject)

    12/6/24 4:12:03 PM ET
    $BEEM
    Semiconductors
    Technology

    SEC Form SC 13G filed by Indivior PLC

    SC 13G - INDIVIOR PLC (0001625297) (Subject)

    11/15/24 6:03:54 PM ET
    $INDV
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by D-Wave Quantum Inc.

    SC 13G/A - D-Wave Quantum Inc. (0001907982) (Subject)

    11/15/24 7:37:26 AM ET
    $QBTS
    EDP Services
    Technology

    $ALBT
    $BEEM
    $GLMD
    $GNLN
    Financials

    Live finance-specific insights

    View All

    Helios Technologies Unveils The CORE 2030 Strategy at 2026 Investor Day and Announces 33% Increase in Quarterly Dividend

    Targets Doubling Sales to $1.6 Billion and 25%+ Adjusted EBITDA margin by 2030 Declares Quarterly Dividend of $0.12 per share Helios Technologies, Inc. (NYSE:HLIO) ("Helios" or the "Company"), a global leader in highly engineered motion control and electronic control technologies, will present The CORE 2030 Strategy and long-term financial targets today at its previously announced 2026 Investor Day. "In 2025, Helios returned to sales growth and delivered a strong fourth quarter exit, expanding margins and strengthening our foundation for the future," said Sean Bagan, President & Chief Executive Officer. "The CORE 2030 Strategy leverages our unique Momentum Model positioning Helios to de

    3/20/26 8:30:00 AM ET
    $HLIO
    Metal Fabrications
    Industrials

    Helios Technologies Continues Long-Standing Partnership with Jacuzzi® Group, Powering All-New J5™ Collection

    Helios Technologies, Inc. (NYSE:HLIO) ("Helios" or the "Company"), a global leader in highly engineered motion control and electronic controls technology, continues its long-standing collaboration with Jacuzzi® Group through its operating company Balboa Water Group, whose display, control, and lighting technologies support the Jacuzzi® J5™ Collection, the newest generation of premium spas from Jacuzzi® Group. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260319021339/en/The Jacuzzi® J5™ Collection includes Balboa's SpaTouch™ 4+ display, spa controller, and custom four-button auxiliary panel, providing an exclusive user interfac

    3/19/26 9:00:00 AM ET
    $HLIO
    Metal Fabrications
    Industrials

    Helios Technologies and Mote Marine Laboratory Partner on Marine Science & Technology Digital Hub at New Science Education Aquarium

    Helios Technologies, Inc. (NYSE:HLIO) ("Helios" or the "Company"), a global leader in highly engineered motion control and electronic control technologies, is proud to announce it is the lead sponsor of the Marine Science & Technology Digital Hub at the new Mote Science Education Aquarium (SEA). This partnership strengthens both organizations' commitments to innovation, technology, and community engagement. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260318879010/en/The Marine Science & Technology Digital Hub, located adjacent to the STEM teaching labs, will serve as a cutting-edge satellite library, connecting SEA visitors t

    3/18/26 9:00:00 AM ET
    $HLIO
    Metal Fabrications
    Industrials